Barclays PLC Has $12.62 Million Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Barclays PLC raised its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 56.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 678,397 shares of the real estate investment trust's stock after purchasing an additional 243,895 shares during the quarter. Barclays PLC owned approximately 0.29% of Sabra Health Care REIT worth $12,624,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SBRA. Nomura Asset Management Co. Ltd. lifted its stake in shares of Sabra Health Care REIT by 4.5% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 315,600 shares of the real estate investment trust's stock worth $5,873,000 after buying an additional 13,600 shares during the last quarter. EP Wealth Advisors LLC bought a new position in Sabra Health Care REIT in the 3rd quarter valued at about $232,000. Wellington Management Group LLP raised its holdings in Sabra Health Care REIT by 736.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,396,835 shares of the real estate investment trust's stock valued at $44,605,000 after acquiring an additional 2,110,307 shares during the period. Systematic Financial Management LP lifted its position in Sabra Health Care REIT by 9.2% during the third quarter. Systematic Financial Management LP now owns 2,292,473 shares of the real estate investment trust's stock worth $42,663,000 after acquiring an additional 192,273 shares during the last quarter. Finally, Quarry LP bought a new stake in shares of Sabra Health Care REIT during the third quarter worth approximately $30,000. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Price Performance

Sabra Health Care REIT stock traded down $0.13 during trading hours on Monday, reaching $17.37. 2,312,581 shares of the stock were exchanged, compared to its average volume of 2,042,824. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT, Inc. has a twelve month low of $12.83 and a twelve month high of $20.03. The company has a market cap of $4.11 billion, a P/E ratio of 42.37, a price-to-earnings-growth ratio of 2.20 and a beta of 1.24. The stock has a 50 day moving average of $18.51 and a two-hundred day moving average of $17.13.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The firm had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. During the same quarter in the prior year, the business posted $0.34 EPS. Equities analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were paid a $0.30 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.91%. Sabra Health Care REIT's payout ratio is 292.69%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on SBRA. Wells Fargo & Company upgraded Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Scotiabank lifted their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a report on Friday, October 11th. Citigroup raised shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their target price for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Mizuho reaffirmed a "neutral" rating and set a $20.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Finally, Truist Financial boosted their price objective on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Sabra Health Care REIT presently has an average rating of "Moderate Buy" and an average price target of $19.14.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.